SEC Form 4 · accession 0001144204-17-049461
Alliqua BioMedical, Inc. · ALQA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Pellegrino Pionati
Officer — See Remarks
Period of report
Sep 21, 2017
Accepted (ET)
Sep 25, 2017 · 4:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054274
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 21, 2017 | F | 69,978 | $0.42 | D | 506,601 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of restricted stock withheld to pay Mr. Pionati's tax withholding obligations incurred in connection with the vesting of 205,715 shares of restricted stock on September 21, 2017.
Remarks
Chief Strategy and Marketing Officer